Genetic Variability of Hepatitis C Virus in Dialysis: The Implications

Stehman-Breen C.O. , Emerson S. , Gretch D. , Johnson R.J. Risk of death among chronic dialysis patients infected with hepatitis C virus. Am J Kidney Dis 1998; 32: 629–34.

Nakayama E. , Akiba T. , Marumo F. , Sato C. Prognosis of anti-hepatitis C virus antibody-positive on regular hemodialysis therapy. J Am Soc Nephrol 2000; 11: 1896–902.

Espinosa M. , Martin-Malo A. , de Lara M.A.M. , Alijama P. Risk of death and liver cirrhosis in anti-HCV positive long-term haemodialysis patients. Nephrol Dial Transplant 2001; 16: 1669–74.

Maisonneuve P. , Agodoa L. , Gellert R. Cancer in patients on dialysis for end-stage renal disease: An international collaborative study. Lancet 1999; 354: 93–9.

Alter M.J. , Margolis H.S. , Krawczynski K. The natural history of community-acquired hepatitis C in the United States. J Engl J Med 1992; 327: 1899–902.

Di Bisceglie M.A. , Goodman Z.D. , Ishak K.G. Long-term clinical and histopathological follow-up of chronic post-transfusion hepatitis. Hepatology 1991; 14: 969–74.

Choo Q.L. , Richman K.H. , Han J.H. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA 1991; 88: 2451–5.

Holland J.J. , De La Torre J.C. , Steinhauer D.A. RNA virus populations as quasispecies. Curr Top Microbiol Immunol 1992; 176: 1–20.

Farci P. , Purcell R.H. Clinical significance of hepatitis C virus genotypes and quasispecies. Semin Liver Dis 2000; 20: 103–26.

Petrosillo N. , Gilli P. , Serraino D. , Dentico P. , Mele A. , Ragni P. , Puro V. , Casalino C. , Ippolito G. , for the Collaborative Group. Prevalence of infected patients and understaffing have a role in hepatitis C virus transmission in dialysis. Am J Kidney Dis 2001; 37: 1004–10.

Jaiswal S.P. , Chitnis D.S. , Salgia P. , Sepaha A. , Pandit C.S. Prevalence of hepatitis viruses among chronic renal failure patients on hemodialysis in Central India. Dial Transplant 2002; 31: 234–40.

Al-Ghamdi S.M.G. , Al-Harbi A.S. Hepatitis C virus sero-status in hemodialysis patients returning from holiday: Another risk factor for HCV transmission. Saudi J Kidney Dis Transplant 2001; 12: 14–20.

Taskapan H. , Oymak O. , Dogukan A. , Utas C. Patient to patient transmission of hepatitis C virus in hemodialysis units. Clin Nephrol 2001; 55: 477–81.

Valtuille R. , Moretto H. , Lef L. , Rendo P. , Fernandez J.L. Decline of high hepatitis C virus prevalence in a hemodialysis unit with no isolation measures during a 6-year follow-up. Clin Nephrol 2002; 57: 371–5.

Saxena A.K. , Panhotra B.R. , Naguib M. Prevalence of hepatitis C antibodies among hemodialysis patients in Al-Hasa region of Saudi Arabia. Saudi J Kidney Dis Transplant 2001; 12: 562–5.

Saxena A.K. , Panhotra B.R. Nosocomial transmission of hepatitis C virus: Impact of strict isolation on annual seroconversion rate in a hemodialysis unit (letter). Saudi J Kidney Dis Transplant 2002; 13: 186–7.

Saab S. , Martin P. , Brezina M. , Gitnick G. , Yee H.F. Serum alanine aminotransferase in hepatitis C screening of patients on hemodialysis. Am J Kidney Dis 2001; 37: 308–15.

Yilmaz Y. , Kara I.H. , Sari Y. , Duzen S. , Usul Y. , Isikoglu B. Seroprevalence and risk factors of HCV in dialysis patients in a university hemodialysis center of Southeast Anatolia, Turkey. Dial Transplant 2001; 30: 748–55.

Aucella F. , Vigilante M. , Valente G.L. , Stallone C. Systematic monitor disinfection is effective in limiting HCV spread in hemodialysis. Blood Purif 2000; 18: 110–4.

Shimizu Y.K. , Feinstone S.M. , Kohara M. Hepatitis C virus: Detection of intracellular virus particles by electronic microscopy. Hepatology 1996; 23: 205–9.

International Union of Microbiological Societies. Murphy F.A. , Fauquet C.M. , Bishop D.H.L. , eds. Virus Taxonomy, 7th ed. New York: Springer-Verlag, 1995: pp. 424–7.

Houghton M. Hepatitis C virus. In: Fields B.N. , Knipe D.M. , Howley P.M. , Chanock R.H. , eds. Fields Virology, 3rd ed. Philadelphia: Lippincott-Raven, 1996: pp. 1035–58.

Tsukiyama-Kohara K. , Kohara I. , Nomoto A. Internal ribosome entry site within hepatitis C virus RNA. J Virol 1992; 66: 1476–83.

Tanaka T. , Kato N. , Cho M. , Shimotohono K. A novel sequence found at the 3′ terminus of hepatitis C virus genome. Biochem Biophys Res Commun 1995, 215: 744–9.

Choo Q.L. , Richman K.H. , Han J.H. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA 1991; 88: 2451–5.

Holland J. , Splinder K. , Horodyski F. Rapid evolution of RNA genomes. Science 1982; 215: 1577–85.

Ogata N. , Alter H.J. , Miller R.H. , Purcell R.H. Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc Natl Acad Sci USA 1991; 88: 3392–6.

Okamoto H. , Koijma M. , Okada S.I. Genetic drift of hepatitis C virus during an 8.2-year infection in a chimpanzee: Variability and stability. Virology 1992; 190: 894–9.

Martell M. , Esteban J.L. , Quer J. Hepatitis C virus circulates as a population of different but closely related genomes: Quasispecies nature of HCV genome distribution. J Virol 1992; 66: 3225–9.

Nowak M.A. Variability of HIV infections. J Theor Biol 1992; 155: 1–20.

Weiner A.J. , Brauer M.J. , Rosemblatt J. Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology 1991; 180: 842–8.

Hijikata M. , Kato N. , Ootsuyama Y. Hypervariable regions in the putative glycoprotein of hepatitis C virus. Biochem Biophys Res Commun 1991; 175: 220–8.

Chan S.W. , McOmish F. , Holmes E.C. Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J Gen Virol 1992; 73: 1131–41.

Simmonds P. Variability of hepatitis C virus. Hepatology 1995; 21: 570–83.

Simmonds P. , Holmes E.C. , Cha T.A. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. Gen Virol 1993; 74: 2391–9.

Forns X. , Bukh J. Methods for determining the hepatitis C virus genotype. Viral Hepat Rev 1998; 4: 1–9.

Purcell R.H. The hepatitis C virus: Overview. Hepatology 1997; 26(Suppl 1): S11–4.

Pozzato G. , Kaneko S. , Moretti M. Different genotypes of hepatitis C virus are associated with different severity of chronic liver disease. J Med Virol 1994; 43: 291–6.

Pozzato G. , Moretti M. , Franzin F. Severity of liver disease with different hepatitis C viral clones (letter). Lancet 1991; 338: 509.

Qu D. , Li S.J. , Vitviski L. Hepatitis C virus genotypes in France: comparison of clinical features of patients infected with HCV type I and II. J Hepatol 1994; 21: 70–5.

Kobayashi M. , Tanaka E. , Sodeyama T. The natural course of chronic hepatitis C: A comparison between patients with genotypes 1 and 2 hepatitis C viruses. Hepatology 1996; 23: 695–9.

Zein N.N. , Poterucha J.J. , Gross J.B. Increased risk of hepatocellular carcinoma in patients infected with hepatitis C genotype 1b. Am J Gastroenterol 1996; 91: 2560–2.

Booth J.C. , Doster G.R. , Levine T. The relationship of histology to genotype in chronic HCV infection. Liver 1997; 17: 144–51.

Lee D.S. , Sung Y.C. , Whang Y.S. Distribution of HCV genotypes among blood donors, patients with chronic liver disease, hepatocellular carcinoma, and patients on maintenance hemodialysis in Korea. J Med Virol 1996; 49: 55–60.

Naoumov N.V. , Chokshi S. , Metivier E. Hepatitis C virus infection in the development of hepatocellular carcinoma in cirrhosis. J Hepatol 1997; 27: 331–6.

Yamada M. , Kakumu S. , Yoshioka K. Hepatitis C virus genotypes are not responsible for development of serious liver disease. Dig Dis Sci 1994; 39: 234–9.

Kobayashi M. , Kumada H. , Chayama K. Prevalence of HCV genotype among patients with chronic liver diseases in the Tokyo metropolitan area. J Gastroenterol 1994; 29: 583–7.

Ravaggi A. , Rossini A. , Mazza C. Hepatitis C virus genotypes in northern Italy: clinical and virological features. J Clin Microbiol 1996; 34: 2822–5.

Guido M. , Rugge M. , Thung S.N. Hepatitis C virus serotypes and liver pathology. Liver 1996; 16: 353–7.

Nousbaum J.B. , Pol S. , Nalpas B. Hepatitis C virus type 1b (II) infection in France and Italy. Ann Intern Med 1995; 122: 161–8.

Lopez-Labrador F.X. , Ampurdanes S. , Forns X. Hepatitis C virus genotypes in Spanish patients with HCV infection: Relationship between genotype 1b, cirrhosis and hepatocellular carcinoma. J Hepatol 1997; 27: 959–65.

Bruno S. , Silini E. , Crosignani A. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis. A prospective study. Hepatology 1997; 25: 754–8.

Benvegnù L. , Pontisso P. , Cavalletto D. , Noventa F. , Chemello C. , Alberti A. Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis. Hepatology 1997; 25: 211–5.

Serfaty L. , Aumaitre H. , Chazouilleres O. Determinants of outcome of compensated hepatitis C virus-related cirrhosis. Hepatology 1998; 27: 1435–40.

Silini E. , Bottelli R. , Asti M. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: A case-control study. Gastroenterology 1996; 111: 199–205.

Hatzakis A. , Katsolidou A. , Kaklamani E. Hepatitis C virus 1b is the dominant genotype in HCV-related carcinogenesis: A case-control study. Int J Cancer 1996; 68: 51–3.

Donato F. , Tagger A. , Chiesa R. Hepatitis B and C virus infection, alcohol drinking and hepatocellular carcinoma: A case-control study. Hepatology 1997; 26: 579–84.

Feray C. , Gigou M. , Samuel D. Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology 1995; 108: 1088–96.

Gordon F.D. , Poterucha J.J. , Germer J. Relationship between hepatitis C genotype and severity of recurrent hepatitis C after liver transplantation. Transplantation 1997; 63: 1419–23.

Zhou S. , Terrault N.A. , Ferrell L. Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: Relationship to genotype and level of viremia. Hepatology 1996; 24: 1041–6.

Vargas H.E. , Laskus T. , Wang L.F. The influence of hepatitis C virus genotypes on the outcome of liver transplantation. Liver Transplant Surg 1998; 4: 22–7.

Davis G.L. , Lau J.Y.N. Factors predictive of a beneficial response to therapy of hepatitis C. Hepatology 1997; 26(Suppl 1): S122–7.

McHutchison J.G. , Gordon S.T. , Schiff E.R. Hepatitis Interventional Therapy Group. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. J Engl J Med 1998; 339: 1485–92.

Davis G.L. , Esteban-Mur R. , Rustgi V. International Hepatitis Interventional Therapy Group. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. J Engl J Med 1998; 339: 1493–9.

Manns M.P. , McHutchison J.G. , Gordon S.C. , and The International Hepatitis Interventional Therapy Group. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial. Lancet 2001; 358: 958–65.

Gomez J. , Martell M. , Quer J. , Cabot B. , Esteban J.I. Hepatitis C viral quasispecies. J Viral Hepat 1999; 6: 3–16.

Eigen M. Self organization of matter and the evolution of biological macromolecules. Naturwissenchaften 1971; 58: 465–523.

Eigen M. , Biebricher C.K. Sequence space and quasispecies distribution. In: Domingo E. , Holland J.J. , Ahlquist P. , eds. RNA genetics. Boca Raton, FL: CRC Press, 1988: pp. 211–45.

Eigen M. , Gradiner W. , Schuster P. , Winkler-Oswatisch R. The origin of genetic information. Sci Am 1981; 244: 78–96.

Domingo E. Biological significance of viral quasispecies. J Viral Hepat 1996; 2: 247–61.

Domingo E. , Holland J.J. High error rates, population equilibrium and evolution of RNA replication systems. In: Domingo E. , Holland J.J. , Ahlquist P. , eds. RNA Genetics, vol. 3. Boca Raton, FL: CRC Press, 1988: pp. 3–36.

Domingo E. Biological significance of viral quasispecies. J Viral Hepat 1996; 2: 247–61.

Domingo E. , Holland J.J. Mutation rates and rapid evolution of RNA viruses. In: Morse S.S. , ed. Evolutionary biology of viruses. New York: Raven Press, 1994: pp. 161–84.

Odeberg J. , Yun Z. , Sonnerborg A. , Bjoro K. , Uhlen M. , Lundeberg J. Variation of hepatitis C virus hypervariable region 1 in immunocompromised patients. J Infect Dis 1997; 175: 938–43.

Toyoda H. , Fukuda Y. , Koyama Y. , Takamatsu J. , Saito H. , Hayakawa T. Effect of immunosuppression on composition of quasispecies population of hepatitis C virus in patients with chronic hepatitis C coinfected with human immunodeficiency virus. J Hepatol 1997; 26: 975–82.

Domingo E. , Sabo D. , Taniguchi T. , Weissmann C. Nucleotide sequence heterogeneity of an RNA phage population. Cell 1978; 13: 735–44.

Branch A.D. , Benenfeld B.J. , Paul C.P. Analysis of ultraviolet-induced RNA-RNA cross-links: A means for probing RNA structure-function relationships. Methods Enzymol 1989; 180: 418–42.

Gretch D.R. , Polyak S.J. The quasispecies nature of hepatitis C virus: Research methods and biological implications. Hepatitis C virus: Genetic heterogeneity and viral load. GEMHEP. Paris: John Libbey Eurotext, 1997: pp. 57–69.

Orita M. , Iwahana H. , Kanazawa H. Detection of polymorphism of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 1989; 86: 2766–70.

Moribe T. , Hayashi N. , Kanazawa Y. Hepatitis C viral complexity detected by single-strand conformation polymorphism and response to interferon therapy. Gastroenterology 1995; 108: 789–95.

Enomoto N. , Kjurosaki M. , Tanaka Y. , Marumo F. , Sato C. Fluctuation of hepatitis C virus quasispecies in persistent infection and interferon treatment revealed by single-strand conformation polymorphism analysis. J Gen Virol 1994; 75: 1361–9.

Lu M. , Funsch B. , Wiese M. , Roggendorf M. Analysis of hepatitis C virus quasispecies populations by temperature gradient gel electrophoresis. J Gen Virol 1995; 76: 881–7.

Wilson J.J. , Polyak S.J. , Day T.D. , Gretch D.R. Characterization of simple and complex hepatitis C virus quasispecies by heteroduplex gel shift analysis: Correlation with nucleotide sequencing. J Gen Virol 1995; 76: 1763–71.

Polyak S.J. , Faulkner G. , Carithers R.J. , Corey L. , Gretch D.R. Assessment of hepatitis C virus quasispecies heterogeneity by gel shift analysis: correlation with response to interferon therapy. J Infect Dis 1997; 175: 1101–7.

Forns X. , Purcell R.H. , Bukh J. Quasispecies in viral persistence and pathogenesis of hepatitis C virus. Trends Microbiol 1999; 7: 402–10.

Farci P. , Alter H.J. , Govindarajan S. Lack of protective immunity against reinfection with hepatitis C virus. Science 1992; 258: 135–40.

Prince A.M. , Brotman B. , Huima T. Immunity in hepatitis C infection. J Infect Dis 1992; 165: 438–43.

Wyatt C.A. , Andrus L. , Brotman B. Immunity in chimpanzees chronically infected with hepatitis C virus: Role of minor quasispecies in reinfection. J Virol 1998; 72: 1725–30.

Lai M.E. , Mazzoleni A. , Argiolu F. Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassemic children. Lancet 1994; 343: 388–90.

Kao J.H. , Chen P.J. , Lai M.Y. , Chen D.S. Superinfection of heterologous hepatitis C virus in a patient with chronic type C hepatitis. Gastroenterology 1992; 105: 583–7.

Okamoto H. , Mishiro S. , Tokita H. Superinfection of chimpanzees carrying hepatitis C virus of genotype II/1b with that of genotype III/2a or I/1a. Hepatology 1994; 20: 1131–6.

Houghton M. , Choo Q.L. , Chien D. Development of an HCV vaccine. In: Rizzetto M. , Purcell R.H. , Gerin J.L. , Verme G. , eds. Viral hepatitis and Liver Disease. Turin: Minerva Medica 1997: pp. 656–9.

Shimizu Y.K. , Iwamoto A. , Hijikata M. Evidence for in vitro replication of hepatitis C virus genome in a human T-cell line. Proc Natl Acad Sci USA 1992; 89: 5477–81.

Farci P. , Shimoda A. , Wong D. Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. Proc Natl Acad Sci USA 1996; 93: 15394–9.

Shimizu Y.K. , Igarashi H. , Kiyohara T. A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures. Virology 1996; 223: 409–12.

Shimizu Y.K. , Hijikata M. , Iwamoto A. Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutants. J Virol 1994; 68: 1494–500.

Weiner A.J. , Geysen H.M. , Christopherson C. Evidence for immune selection of hepatitis C viruas putative envelope glycoprotein variants. Potential role in chronic HCV infection. Proc Natl Acad Sci USA 1992, 89: 3468–72.

Kato N. , Sekiya H. , Ootsuyama Y. Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus. J Virol 1993; 67: 3923–30.

Lesniewski R.R. , Boardway K.M. , Casey J.M. Hypervariable 5′-terminus of hepatitis C virus E2/NS1 encodes antigenically distinct variants. J Med Virol 1993; 40: 150–6.

Scarselli E. , Cerino A. , Esposito G. Occurrence of antibodies reactive with more than one variant of the putative envelope glycoprotein (E2; gp70) hypervariable region 1 in hepatitis C viremic patients. J Virol 1995; 69: 4407–12.

Taniguchi S. , Okamoto H. , Sakamoto M. A structurally flexible and antigenically variable N-terminal domain of the hepatitis C virus (E2/NS1) protein: Implication for an escape from antibody. Virology 1993; 195: 297–301.

Van Doorn L.J. , Capriles I. , Maertens G. Sequence evolution of the hypervariable region in the putative envelope region E2/NS1 of hepatitis C virus is correlated with specific humoral immune response. J Virol 1995; 69: 773–8.

McAllister J. , Casino C. , Davidson F. Long-term evolution of the hypervariable region of hepatitis C virus in a common-source-infected cohort. J Virol 1998; 72: 4893–905.

Fried M.W. , Hoofnagle J.H. Therapy of hepatitis C. Semin Liver Dis 1995; 15: 82–91.

Okada S. , Akahane Y. , Suzuki H. The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients. Hepatology 1992; 16: 619–24.

Toyoda H. , Kumada T. , Nakano S. Quasispecies nature of hepatitis C virus and response to alpha interferon; significance as a predictor of direct response to interferon. J Hepatol 1997; 26: 6–13.

Mizokami M. , Lau J.Y.N. , Suzuki K. Differential sensitivity of hepatitis C virus quasispecies to interferon therapy. J Hepatol 1994; 21: 884–6.

Gonzalez-Peralta R.P. , Qian K. , She J.Y. Clinical implications of viral quasispecies heterogeneity in chronic hepatitis C. J Med Virol 1996; 49: 242–7.

Le Guen B. , Squadrito G. , Nalpas B. Hepatitis C virus genome complexity correlates with response to interferon therapy: A study in French patients with chronic hepatitis C. Hepatology 1997; 25: 1250–4.

Pawlotsky J.M. , Pellerin M. , Bouvier M. Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): Influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C. J Med Virol 1998; 54: 256–264.

Hagiwara H. , Hayashi N. , Kasahara A. Treatment with recombinant interpheron-alpha 2a for patients with chronic hepatitis C: Predictive factors for biochemical and virologic response. Osaka Liver Disease Study Group. Scand J Gastroenterol 1996; 31: 1021–6.

Shindo M. , Hamada K. , Koya S. The clinical significance of changes in genetic heterogeneity of the hypervariable region 1 in chronic hepatitis C with interferon therapy. Hepatology 1996; 24: 1018–23.

Polyak S.J. , Faulkner G. , Carithers R.L. Assessment of hepatitis C virus quasispecies heterogeneity by gel shift analysis: Correlation with response to interferon therapy. J Infect Dis 1997; 175: 1101–7.

Enomoto N. , Sakuma I. , Asahina Y. Comparison of full-length sequences of interferon sensitive and resistant hepatitis C virus 1b. J Clin Invest 1995; 96: 224–30.

Enomoto N. , Sakuma I. , Asahina Y. Mutations in the non-structural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. J Engl J Med 1996; 334: 77–81.

Gale M.J. , Korth M.J. , Tang N.M. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural A protein. Virology 1997; 230: 217–27.

Fabrizi F. , Poordad F.F. , Martin P. Diagnostic workup of hepatitis C and the patient on maintenance dialysis. Int J Artif Organs 2001; 24: 843–52.

Fabrizi F. , Lunghi G. , Pagliari B. Molecular epidemiology of hepatitis C virus infection in dialysis patients. Nephron 1997; 77: 190–6.

Fabrizi F. , Martin P. , Quan S. Serotyping strip immunoblot assay for assessing hepatitis C virus strains in dialysis patients. Am J Kidney Dis 2000; 35: 832–8.

Fabrizi F. , Martin P. , Dixit V. Biological dynamics of viral load in hemodialysis patients with hepatitis C virus. Am J Kidney Dis 2000; 35: 122–9.

Natov S.N. , Lau J.Y.N. , Ruthazer R. and The New England Organ Bank Hepatitis C Study Group. Hepatitis C virus genotype does not affect patient survival among renal transplant candidates. Kidney Int 1999; 56: 700–6.

Fabrizi F. , Martin P. , Lunghi G. , Ponticelli C. Nosocomial transmission of hepatitis C virus in hemodialysis patients: Clinical perspectives. Int J Artif Organs 2000; 23: 805–16.

Sullivan D.G. , Kim S.S. , Wilson J.J. Investigating hepatitis C virus heterogeneity in a high prevalence setting using heteroduplex tracking analysis. J Virol Methods 2001; 96: 5–16.

Gretch D.R. , Polyak S.J. , Wilson J.J. Tracking hepatitis C virus quasispecies major and minor variants in symptomatic and asymptomatic liver transplant recipients. J Virol 1996; 70: 7622–31.

Sullivan D.G. , Wilson J.J. , Carithers R.L. Multigene tracking of hepatitis C virus quasispecies after liver transplantation: correlation with genetic diversification in the envelope region with asymptomatic or mild disease patterns. J Virol 1998; 72: 10036–43.

Gerotto M. , Sullivan D.C. , Polyak S.J. Effect of retreatment with interferon alone or interferon plus ribavirin on hepatitis C virus quasispecies diversification in nonresponder patients with chronic hepatitis C. J Virol 1999; 73: 7241–7.

Fabrizi F. , Lunghi G. , Guarnori I. Hepatitis C virus genotypes in chronic dialysis patients. Nephrol Dial Transplant 1996; 11: 679–83.

Lau J.Y.N. , Davis G.L. , Prescott L.E. Distribution of hepatitis C virus genotypes in United States patients with chronic hepatitis C seen in tertiary referral centers. Ann Intern Med 1996; 124: 868–76.

Qian K.P. , Natov S.N. , Pereira B.J.G. , Lau J.Y.N. Hepatitis C virus mixed genotype infection in patients on haemodialysis. J Viral Hepat 2000; 7: 153–60.

Ohba K. , Mizokami M. , Ohno T. Classification of hepatitis C virus into major types and subtypes based on molecular evolutionary analysis. Virus Res 1995; 36: 201–14.

Natov S.N. , Lau J.Y.N. , Bouthot B.A. , and the New England Organ Bank Hepatitis C Study Group. Serologic and virologic profiles of hepatitis C infection in renal transplant candidates. Am J Kidney Dis 1998; 31: 920–27.

Bosmans J.L. , Nouwen E.J. , Behets G. , and the collaborating centres from Belgium and Saudi Arabia. Prevalence and clinical expression of HCV-genotypes in haemodialysis-patients of two geographically remote countries: Belgium and Saudi Arabia. Clin Nephrol 1997; 47: 256–62.

Colleoni N. , Bucci R. , Ribero M.L. Hepatitis C virus genotype in anti-HCV positive hemodialysed patients. Nephrol Dial Transplant 1996; 11: 2258–64.

Bouchardeau F. , Chauveau P. , Couroucè A.M. , Poignet J.L. Genotype distribution and transmission of hepatitis C virus in French haemodialysed patients. Nephrol Dial Transplant 1995; 10: 2250–2.

Furusyo N. , Hayashi J. , Ariyama I. Maintenance hemodialysis decreases serum hepatitis C virus (HCV) RNA levels in hemodialysis patients with chronic HCV infection. Am J Gastroenterol 2000; 95: 490–6.

Sampietro M. , Badalamenti M. , Salvatori S. High prevalence of a rare hepatitis C virus in patients treated in the same dialysis unit: Evidence for nosocomial transmission of HCV. Kidney Int 1995; 47: 911–7.

Goessens C. , Jadoul M. , Walon C. Hepatitis C virus genotypes in hemodialyzed patients: A multicentric study. Clin Nephrol 1997; 47: 367–71.

Van Doorn L.J. , Kleter B. , Pike I. , Quint W. Analysis of hepatitis C virus isolates by serotyping and genotyping. J Clin Microbiol 1996; 34: 1784–7.

Beccari M. , Tagger A. , Romagnoni M. Anti-HCV prevalence, viraemic status, and genotype distribution in an Italian haemodialysis population (letter). Nephrol Dial Transplant 1996; 11: 907–8.

Chou W.H. , Lin S.F. , Sheu S.H. Comparison of hepatitis C virus strains obtained from hemodialysis patients. Jpn J Med Sci Biol 1993; 46: 191–202.

Canavese C. , Hollò Z. , Ciccone G. Extrahepatic immunological manifestations of hepatitis C virus in dialysis patients. J Nephrol 2000; 13: 352–9.

Pol S. , Thiers V. , Nousbaum J.B. The changing relative prevalence of hepatitis C virus genotypes: Evidence in hemodialyzed patients and kidney recipients. Gastroenterology 1995; 108: 581–3.

Chan T.M. , Lau J.Y.N. , Wu P.C. Hepatitis C virus genotypes in patients on renal replacement therapy. Nephrol Dial Transplant 1998; 13: 731–4.

Simmonds P. , Alberti A. , Alter H.J. A proposed system for the nomenclature of hepatitis C virus genotypes. Hepatology 1994; 19: 1321–4.

Hadiwondowo S. , Tsuda F. , Okamoto H. Hepatitis B virus subtypes and hepatitis C virus genotypes in patients with chronic liver disease or on maintenance hemodialysis in Indonesia. J Med Virol 1994; 43: 182–6.